(Press-News.org) Sandra Shi MD, MPH, has been named a 2025 STAT Wunderkind. Dr. Shi is a geriatrician, instructor in medicine at Harvard Medical School, and assistant scientist at the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife.
STAT Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program leaders. It honors postdoctoral researchers, interns, and fellows — those who have terminal degrees in hand, but aren’t running their own research programs yet.
Dr. Shi joins Amir Baniassadi, PhD, an instructor of medicine at Harvard Medical School and an assistant scientist at the Marcus Institute, who was named a 2023 STAT Wunderkind.
Dr. Sandra Shi’s STAT Profile
Sandra Shi hadn’t heard the term geriatrics before she started volunteering at a nursing home in college. She helped older adults do stretches and leg lifts while they recovered from injuries or hip replacements. Watching them progress and regain their ability to live independently ignited a passion that altered the course of her career.
Geriatrics, the specialty focused on providing high-quality care to older adults, is practiced in the way that medicine should be, Shi said. Geriatricians sometimes go into people’s homes. They meet their families, hear their stories. “At the end of the day, I like that it comes down to you and that patient and what their priorities are and what matters to them,” Shi said.
As a researcher, Shi is focused on using data to improve people’s lives. Her work was the first to use national Medicare claims to create a frailty index — a tool that uses grip strength, gait speed, and other factors to measure the health status of older adults in a given population — for older adults in the U.S. today. Now, she’s trying to take that to the next level by encouraging federal health programs and health care providers to use it to predict how people will respond to surgeries, medications, and other interventions and tailor their treatment based on the results.
Shi still spends a good chunk of her time doing rehabilitation with older adults in nursing homes, work that she finds meaningful and that helps her understand how her research will actually help people in the real world. “I really love that I have that feedback,” Shi said.
About Sandra Shi
Dr. Shi completed her medical degree and residency in internal medicine at the University of Chicago. She pursued specialized training in geriatrics at the Harvard Medical School Multi-Campus Fellowship in Geriatric Medicine and a T32 post-doctoral fellowship. Dr. Shi’s research revolves around frailty and post-acute care rehabilitation in skilled nursing facilities. She leverages large-scale databases, including national surveys and Medicare claims data, to delve into frailty and its influence on recovery for older adults. Her ultimate goal is to improve recovery for frail older adults after hospitalization with novel interventions that meld geriatrics and rehabilitation science. Her research has been published in high-impact journals, including JAMA Internal Medicine and JAMA Network Open.
Most recently, Dr. Shi was awarded a $1.2 Million NIA K76 Beeson award to study intrinsic capacity in post-acute rehabilitation. In 2024, she was also honored with the Health in Aging Foundation New Investigator Award from the American Geriatrics Society for her impactful frailty and post-acute care research. Her multidimensional approach to aging research continues to shape the future of geriatric care, emphasizing personalized, patient-centered outcomes that empower older adults and their families in decision-making processes.
About STAT
STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Millions of new readers turned to STAT as the publication sounded the alarm about the COVID-19 pandemic early on. STAT journalists go deep in tough-minded coverage of the business of making medicines, health tech, science, and public health.
STAT takes you inside academic labs, biotech boardrooms, and political backrooms. They cast a critical eye on scientific discoveries, scrutinize corporate strategies, and chronicle roiling battles for talent, money, and market share. They examine controversies and puncture hype. With an award-winning newsroom, STAT gives you indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life science industry — and a revolution in human health. These are the stories that matter to us all.
About Hebrew SeniorLife
Hebrew SeniorLife, an affiliate of Harvard Medical School, is a national senior services leader uniquely dedicated to rethinking, researching, and redefining the possibilities of aging. Hebrew SeniorLife cares for more than 4,500 seniors a day across seven campuses throughout Greater Boston. Locations include: Hebrew Rehabilitation Center-Boston and Hebrew Rehabilitation Center-NewBridge in Dedham; NewBridge on the Charles, Dedham; Orchard Cove, Canton; Simon C. Fireman Community, Randolph; Center Communities of Brookline, Brookline; Jack Satter House, Revere; and Leyland Community, Dorchester. Founded in 1903, Hebrew SeniorLife also conducts influential research into aging at the Hinda and Arthur Marcus Institute for Aging Research, which has a portfolio of more than $98 million, making it one of the largest gerontological research facilities in the U.S. in a clinical setting. It also trains more than 500 geriatric care providers each year. For more information about Hebrew SeniorLife, follow us on our blog, Facebook, Instagram, Threads, and LinkedIn.
About the Hinda and Arthur Marcus Institute for Aging Research
Scientists at the Marcus Institute seek to transform the human experience of aging by conducting research that will ensure a life of health, dignity, and productivity into advanced age. The Marcus Institute carries out rigorous studies that discover the mechanisms of age-related disease and disability; lead to the prevention, treatment, and cure of disease; advance the standard of care for older people; and inform public decision-making.
END
Sandra Shi MD, MPH, named 2025 STAT Wunderkind
Dr. Shi honored for early-career research that uses data to improve care for older adults.
2025-10-17
ELSE PRESS RELEASES FROM THIS DATE:
Treating liver disease with microscopic nanoparticles
2025-10-17
Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United States alone — the ninth most common cause of death in the nation.
Despite this significant impact on society, alcohol-related liver disease (ARLD) remains largely unaddressed by medical research. Texas A&M University researcher Dr. Jyothi Menon aims to change that with a promising new therapy that she’s developing. ...
Chemicals might be hitching a ride on nanoplastics to enter your skin
2025-10-17
Plastic is ubiquitous in the modern world, and it’s notorious for taking a long time to completely break down in the environment — if it ever does.
But even without breaking down completely, plastic can shed tiny particles — called nanoplastics because of their extremely small size — that scientists are just now starting to consider in long-term health studies.
One of those scientists is Dr. Wei Xu, an associate professor in the Texas A&M College of Veterinary Medicine and Biomedical Sciences’ Department of Veterinary Physiology & Pharmacology. Xu’s ...
Pregnant patients with preexisting high cholesterol may have elevated CV risk
2025-10-17
Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early cardiovascular events in the first five-years postpartum, according to a new study being presented at ACC’s Cardio-Obstetrics Essentials: Team-Based Management of Cardiovascular Disease and Pregnancy conference. The researchers call for clinicians to incorporate lipid screening into preconception care and closely monitor women with hyperlipidemia during and after pregnancy.
“Pre-pregnancy hyperlipidemia is not just a metabolic concern; it ...
UC stroke experts discuss current and future use of AI tools in research and treatment
2025-10-17
As artificial intelligence (AI) use continues to grow in nearly every industry, it is important to establish guardrails to make sure the technology is used ethically and responsibly. This is especially true in the field of medicine, where errors can be a matter of life and death and patient information must be protected.
A group of stroke physicians, researchers and industry representatives discussed the current use and future of AI in stroke clinical trial design at the Stroke Treatment Academic Industry Roundtable meeting March 28. Led by the University of Cincinnati’s Joseph Broderick, MD, the researchers published an article in the ...
The Southern Ocean’s low-salinity water locked away CO2 for decades, but...
2025-10-17
Climate models suggest that climate change could reduce the Southern Ocean’s ability to absorb carbon dioxide (CO2). However, observational data actually shows that this ability has seen no significant decline in recent decades. In a recent study, researchers from the Alfred Wegener Institute have discovered what may be causing this. Low-salinity water in the upper ocean has typically helped to trap carbon in the deep ocean, which in turn has slowed its release into the atmosphere – until now, that is, because climate change is increasingly altering the Southern Ocean and its function as a carbon sink. The study ...
OHSU researchers develop functional eggs from human skin cells
2025-10-17
Researchers at Oregon Health & Science University have accomplished a unique proof of concept to treat infertility by turning skin cells into eggs capable of producing early human embryos.
The research published today in the journal Nature Communications.
The development offers a potential avenue for in vitro gametogenesis — the process of creating gametes — to treat infertility for women of advanced maternal age or those who are unable to produce viable eggs due to previous treatment of cancer or other causes.
“In addition to offering hope for millions of people with infertility due to ...
Most users cannot identify AI bias, even in training data
2025-10-17
UNIVERSITY PARK, Pa. — When recognizing faces and emotions, artificial intelligence (AI) can be biased, like classifying white people as happier than people from other racial backgrounds. This happens because the data used to train the AI contained a disproportionate number of happy white faces, leading it to correlate race with emotional expression. In a recent study, published in Media Psychology, researchers asked users to assess such skewed training data, but most users didn’t notice the bias — unless they were in the negatively portrayed group.
The study was designed to examine whether laypersons understand that unrepresentative data used to train ...
Hurricane outages: Analysis details the where, and who, of increased future power cuts
2025-10-17
Images
Georgia and northern Florida are likely to be hardest hit by increasing hurricane-induced power outages along the Atlantic coast in the future, with Hispanic, non-white, low-income and elderly populations most affected, according to new research led by the University of Michigan.
Hurricanes are predicted to become even more frequent and severe in the coming years if the planet's temperatures rise by another 1.5 degrees Celsius over pre-industrial levels—expected by the end of the century without drastic action taken.
The total 3 C rise will bring increased outages to areas ...
Craters on surface of melanoma cells found to serve as sites for tumor killing
2025-10-17
Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, becoming major sites for tumor killing. These craters could serve as good markers for immunotherapy success.
This research provides insight into a key function of immune check-point blockade (ICB) cancer therapy that was previously unknown. ICB works by re-activating CD8+ T cells against tumors which shrinks and eventually kills the cancer cells. However, what facilitates local tumor killing by the infiltrating CD8+ T cells has remained a ...
Research Spotlight: Mapping overlooked challenges in stroke recovery
2025-10-17
Nirupama Yechoor, MD, MSC, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in JAMA Network Open, “Coherence of Stroke Survivors’ Lived Experiences and the Stroke Specific Quality of Life Scale.”
Q: How would you summarize your study for a lay audience?
As doctors who care for stroke survivors, we recognize that recovery is a long journey shaped by physical, emotional, mental and social challenges that extend beyond the hospital walls. We also recognize that many changes are needed to help all stroke survivors achieve their best recovery, which means optimizing both their health and their wellbeing. ...
LAST 30 PRESS RELEASES:
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments
Using smartphones to improve disaster search and rescue
Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing
Ultrafast material captures toxic PFAS at record speed and capacity
Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli
[Press-News.org] Sandra Shi MD, MPH, named 2025 STAT WunderkindDr. Shi honored for early-career research that uses data to improve care for older adults.